![Dale Boger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dale Boger
Corporate Officer/Principal presso The Scripps Research Institute
Posizioni attive di Dale Boger
Società | Posizione | Inizio | Fine |
---|---|---|---|
The Scripps Research Institute
![]() The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | 01/01/1991 | - |
Storia della carriera di Dale Boger
Precedenti posizioni note di Dale Boger
Società | Posizione | Inizio | Fine |
---|---|---|---|
Purdue University | Corporate Officer/Principal | 01/01/1991 | 01/01/1991 |
University of Kansas | Corporate Officer/Principal | 01/01/1985 | 01/01/1985 |
CombiChem, Inc.
![]() CombiChem, Inc. Miscellaneous Commercial ServicesCommercial Services CombiChem, Inc. used to provide computational drug recovery services to accelerate the discovery process for new drugs and chemical compounds. The company was founded in 1994 and headquartered in San Diego, CA | Fondatore | - | - |
Abide Therapeutics, Inc.
![]() Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Fondatore | 01/01/2011 | - |
Formazione di Dale Boger
University of Kansas | Undergraduate Degree |
Harvard University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Posizioni
Corporate Officer/Principal | 3 |
Founder | 2 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 5 |
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Abide Therapeutics, Inc.
![]() Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Health Technology |
CombiChem, Inc.
![]() CombiChem, Inc. Miscellaneous Commercial ServicesCommercial Services CombiChem, Inc. used to provide computational drug recovery services to accelerate the discovery process for new drugs and chemical compounds. The company was founded in 1994 and headquartered in San Diego, CA | Commercial Services |
- Borsa valori
- Insiders
- Dale Boger
- Esperienza